British American Tobacco Share Discussion Threads

[philanderer] 09/7/2020 13:44

"US FDA authorizes marketing of IQOS as a Modified Risk Tobacco Product"


The U.S. Food and Drug Administration (FDA) yesterday authorized the marketing of IQOS, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP).

In doing so, the US FDA found that an IQOS exposure modification order is appropriate to promote the public health.

The decision demonstrates that IQOS is a fundamentally different tobacco product and a better choice for adults who would otherwise continue smoking.

IQOS is the first and only electronic nicotine product to be granted marketing orders through the FDA’s MRTP process.

[18bells] 09/7/2020 13:33

Bats seems to go the opposite to the general market. It will be back up soon.

[philanderer] 09/7/2020 10:09

9th july UBS buy tp 3800p up from 3200p

[saltaire111] 09/7/2020 09:34

Ex-d today, as confirmed by popper above.

[18bells] 09/7/2020 08:19

Close to divi day?

[p0pper] 09/7/2020 08:19

ex divi today kiwi

[kiwi2007] 09/7/2020 08:15

Big drop/ Any particular reason?

[philanderer] 01/7/2020 09:07

Goldmans initiates coverage with 'buy' .. tp 4000p

[spoole5] 10/6/2020 16:53

Will struggle to find a more reliable stock in the current environment.

[philanderer] 10/6/2020 13:16

BATS the best one of my lot today :-)

[ariane] 10/6/2020 12:52

Credit Suisse Outperform 4,070.00 - Reiterates

[muscletrade] 10/6/2020 12:22

Ooops!!! missed one.

Already positive, the research from UBS and its analyst Nik Oliver still consider the stock as a Buy opportunity.. The target price is unchanged at GBX 3200.

[muscletrade] 10/6/2020 08:04

Barclays reiterates overweight and Deutsche reiterates buy.

I rest my case :)

[muscletrade] 10/6/2020 06:43

In a research note, RBC analyst James Edwardes Jones has maintained his recommendation on the stock with a Neutral rating. The target price is unchanged at GBp 2600.

[muscletrade] 10/6/2020 06:42

In his latest research note, analyst Owen Bennett confirms his positive recommendation. The broker Jefferies is keeping its Buy rating. The target price is unchanged at GBp 4800.

[muscletrade] 10/6/2020 06:42

Celine Pannuti from JP Morgan retains his positive opinion on the stock with a Buy rating. The target price is unchanged at GBp 4250.

[muscletrade] 10/6/2020 06:41

Credit Suisse remains its Buy rating
Already positive, the research from Credit Suisse and its analyst Alan Erskine still consider the stock as a Buy opportunity.. The target price is unchanged at GBX 4070.